AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Stoke TherapeuticsRhythm PharmaceuticalsMyovant SciencesAthenexMolecular Templates
SymbolNASDAQ:STOKNASDAQ:RYTMNYSE:MYOVNASDAQ:ATNXNASDAQ:MTEM
Price Information
Current Price$25.45$19.80$17.75$11.41$15.59
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.21.51.92.11.6
Analysis Score3.53.43.43.53.5
Community Score2.72.52.62.52.6
Dividend Score0.00.00.00.00.0
Ownership Score0.01.03.04.02.0
Earnings & Valuation Score0.00.60.60.60.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$36.50$34.29$27.00$28.00$21.00
% Upside from Price Target43.42% upside73.16% upside52.11% upside145.40% upside34.70% upside
Trade Information
Market Cap$912.03 million$872.98 million$1.10 billion$931.40 million$709.39 million
BetaN/A0.942.561.022.44
Average Volume184,721236,4931,030,476633,370305,470
Sales & Book Value
Annual RevenueN/AN/AN/A$101.23 million$22.27 million
Price / SalesN/AN/AN/A9.2032.00
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$6.86 per share$6.40 per share($1.21) per share$2.15 per share$2.79 per share
Price / BookN/AN/AN/A5.315.59
Profitability
Net Income$-32,330,000.00$-140,730,000.00$-288,990,000.00$-123,750,000.00$-69,420,000.00
EPS($1.80)($3.86)($3.37)($1.67)($1.26)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-87.86%-439.48%
Return on Equity (ROE)-16.47%-67.50%-2,288.94%-67.88%-76.76%
Return on Assets (ROA)-16.10%-60.13%-172.45%-35.46%-45.17%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.01%5.88%0.38%0.17%
Current Ratio39.56%15.14%1.02%2.84%2.83%
Quick Ratio39.56%15.14%1.02%2.37%2.83%
Ownership Information
Institutional Ownership PercentageN/A92.03%34.22%56.81%52.76%
Insider Ownership PercentageN/A9.49%3.68%16.30%42.60%
Miscellaneous
Employees44548657568
Shares Outstanding32.97 million44.09 million89.87 million81.63 million45.71 million
Next Earnings Date8/12/2020 (Estimated)8/3/2020 (Estimated)8/4/2020 (Estimated)8/5/2020 (Estimated)8/10/2020 (Estimated)
OptionableNot OptionableOptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.